Lymph node removal enhances corneal graft survival in mice at high risk of rejection

BMC Ophthalmology

Volumn 4, Issue , 2004, Pages 1-7

  Plšková, Jarmila ^a,b,c   Holá, Vladimír ^b   Filipec, Martin ^c   Forrester, John V ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA INJURY; CORNEA TRANSPLANTATION; CORNEA VASCULARIZATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK POPULATION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; LYMPH NODE; LYMPHADENECTOMY; MALE; MOUSE; NONHUMAN; SKIN ALLOGRAFT; SKIN SENSITIZATION; SPLEEN CELL; SUBMANDIBULAR GLAND; SUPPRESSOR CELL; SURVIVAL TIME; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 2942560179     PISSN: 14712415     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-4-3     Document Type: Article

References (15)

1. Yamagami S, Dana MR: The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001, 42:1293-1298.
2. Plskova J, Duncan L, Holan V, Filipec M, Kraal G, Forrester JV: The immune response to corneal allograft requires a site-specific draining lymph node. Transplantation 2002, 73:210-215.
3. Yamagami S, Dana MR, Tsuru T: Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea 2002, 21:405-409.
4. Faunce ED, Stein-Streilein J: NKT cell-derived RANTES recruits APCs and CD8+ cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002, 169:31-38.
5. She S-C, Steahly LP, Moticka EJ: A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg 1990, 21:781-785.
6. Plskova J, Kuffova L, Holan V, Filipec M, Forrester JV: Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol 2002, 86:108-113.
7. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM, Kraal G: Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999, 162:1994-1998.
8. Holan V, Hasek M, Chutna J, Holoubkova I: Mechanisms of tolerance of the Ia antigen disparate skin allografts. Folia Biol (Praha) 1982, 28:395-408.
9. Haskova Z, Filipec M, Holan V: The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice. Folia Biol (Praha) 1996, 42:105-111.
10. Hasek M, Holan V, Chutna J: Comparison of neonatally and adoptively induced transplantation tolerance in mice. Folia Biol (Praha) 1980, 26:167-175.
11. Kataoka M, Margenthaler JA, Ku G, Flye MW: Development of infectious tolerance after donor-specific transfusion and rat heart transplantation. J Immunol 2003, 171:204-211.
12. Kataoka M, Margenthaler JA, Ku G, Eilers M, Flye MW: "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants. Surgery 2003, 134:227-234.
13. Sano Y, Ksander BR, Streilein JW: Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995, 36:2176-2185.
14. Sano Y, Ksander BR, Streilein JW: Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 1997, 38:1130-1138.
15. Dana MR, Yamada J, Streilein JW: Topical interleukin I receptor antagonist promotes corneal transplant survival. Transplantation 1997, 63:1501-1507.